Bohai Pharmaceuticals Group, Inc. (BOPH) Return on Investment ROI from the first quarter of 2015 to first quarter of 2014 and for the year 2015, average high and low, overall ranking from Sep 30 2014 to Sep 30 2013 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bohai Pharmaceuticals Group, Inc.  (BOPH)


Bohai Pharmaceuticals Group,'s ROI from its first quarter of 2015 to the first quarter of 2014 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bohai Pharmaceuticals Group,'s ROI in the first quarter of 2015?
Bohai Pharmaceuticals Group, Inc. achieved a return on average invested assets (ROI) of 15.37 % in its first quarter of 2015, this is above BOPH's average return on investment of 15.05%.
Bohai Pharmaceuticals Group, Inc. invested over the 12 months ending in its first quarter of 2015 $151 million

ROI fell compared to the fourth quarter of 2014, despite the net income growth of 141.8% from the fourth quarter of 2014.

Within the Healthcare sector 90 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2014 from 610 to 658.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2014)
I. Quarter		 (Jun 30 2014)
IV. Quarter		 (Mar 31 2014)
III. Quarter		 (Dec 31 2013)
II. Quarter		 (Sep 30 2013)
I. Quarter
Y / Y Investment Change TTM 19.77 % 16.15 % 14.4 % 15.46 % 15.51 %
Y / Y Net Income Change TTM 11.19 % 14.46 % 50.77 % 85.05 % 225.47 %
Investment (TTM) in Millions 169 147 144 142 135
Return On Investment (TTM) 15.37 % 15.41 % 16.33 % 16.41 % 16.55 %
BOPH's Overall Ranking # 658 # 610 # 666 # 514 # 534
Seq. Investment Change TTM 6.02 % 3.9 % 4.05 % 4.5 % 2.81 %
Seq. Net Income Change TTM 5.74 % -2 % 3.56 % 3.6 % 8.85 %
Net Income (TTM) in Millions 23 22 22 22 21

BOPH Company Profile >> Back to BOPH Roi Comparisons >> See Annual BOPH Return On Investment



Return On Investment BOPH's Ranking
Within: No.
Industry # 15
Sector # 91
Overall # 658

Return On Investment Statistics
High Average Low
16.39 %
15.05 %
10.64 %
(Sep 30 2013)   (Mar 31 2012)







Financial Statements
Bohai Pharmaceuticals Group,'s I. Quarter Investments $ 169 Millions BOPH's Balance sheet
Bohai Pharmaceuticals Group,'s I. Quarter Income $ 9 Millions Quarterly BOPH's Income Statement
BOPH's Income by Division See BOPH's Income by Division


BOPH Annual Return On Investment (Jun 30 2014)
2014		 (Jun 30 2013)
2013		 (Jun 30 2012)
2012

Total Investments in Millions 147 126 115 0 0
Y / Y Investment Growth 16.92 % 9.73 % - - -
Net Income in Millions 22 19 10 0 0
Y / Y Net Income Growth 14.46 % 98.21 % - - -
Annual Return On Investment 14.84 % 15.16 % 8.39 % - -


Annual Roi Comment
In the fiscal year 2014 ROI deteriorated to 14.84 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BOPH's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BOPH's Competitors
Subscribers only: Roi for Bohai Pharmaceuticals Group,'s Suppliers
Subscribers only: Return On Investment for BOPH's Customers

Other Ratios
BOPH's Roa BOPH's Inventory Turnover Ratio BOPH's Growth Rates BOPH's Dividend Statistics
BOPH's Profitability Ratios BOPH's Asset Turnover Ratio BOPH's Dividend Growth
BOPH's Roe BOPH's Valuation Ratios BOPH's Financial Strength Ratios BOPH's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2014, within Healthcare Sector ROI
Applied Genetic Technologies Corporation  41.89 %
Iveric Bio Inc   41.28 %
Astrotech Corp  40.69 %
Aratana Therapeutics, Inc.  39.31 %
Scientific Industries Inc   36.85 %
Agios Pharmaceuticals Inc   36.25 %
Sunwin Stevia International Inc.  35.91 %
Lifevantage Corp  35.55 %
Lannett Company Inc  34.49 %
Bioage Labs Inc   33.99 %
Tenax Therapeutics Inc   33.39 %
Insys Therapeutics, Inc.  32.14 %
Portola Pharmaceuticals inc   31.48 %
Vbi Vaccines Inc  30.97 %
Oramed Pharmaceuticals Inc  30.64 %
Edwards Lifesciences Corporation  29.96 %
Cv Sciences Inc   28.24 %
China Biologic Products Holdings Inc   27.77 %
Luna Innovations Inc  26.49 %
Enanta Pharmaceuticals Inc  26.34 %
Biogen Inc   23.07 %
Remedent Inc   22.62 %
Anika Therapeutics Inc   22.39 %
Idexx Laboratories Inc  21.89 %
Meridian Bioscience Inc   21.62 %
Ani Pharmaceuticals Inc  21.61 %
Mettler toledo International Inc   21.20 %
Iqvia Holdings Inc   20.74 %
Psychemedics Corporation  20.54 %
Fonar Corporation  20.17 %

Date modified: 2026-09-12T06:21:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.